- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02298751
Exposure Therapy as Aftercare for Alcohol Use Disorder
Alcohol Cue Exposure: An Investigator-blinded, Randomized, Controlled Study of Exposure-based Aftercare in Alcohol Use Disorder Individuals
Background: It is well documented that individuals with Alcohol Use Disorder (AUD) respond well during evidence-based psychological treatment, but also that a large proportion relapse when discharged from treatment and confronted with alcohol in real life. Cue Exposure Therapy (CET) focuses on confronting alcohol cues in order to reduce cravings as well as the likelihood of relapse. The aim of this study is to investigate whether CET as aftercare increases the efficiency of Cognitive Behavioural Therapy (CBT) among AUD individuals.
Design and methods: The study is implemented as an investigator-blinded randomized controlled trial. A total of 300 consecutively enrolled AUD patients, recruited from an alcohol outpatient clinic will be randomized to one of the three following aftercare treatment groups: (A) CET as a smartphone application (n = 100); (B) CET as group therapy (n = 100), and (C) Aftercare as Usual (n = 100). It is hypothesized that the two experimental groups ((A) and (B)) will achieve better treatment outcomes as compared to the control group ((C)), and It will be explored whether CET as smartphone application is as effective as CET as group therapy. The groups will be compared in a number of parameters including alcohol intake, cravings and copings-strategies.
Discussion: If the hypothesis, that CET increases the efficiency of CBT is verified, it will make sense to supplement CBT with CET as aftercare, hence, reintegrating CET within a CBT approach. Although, CET is most often regarded as one of the behavioral methods in CBT, there appears to be segregation in the empirical literature when it comes to treatment of addictive disorders. However, CET may allow the patient to practice and gain control over alcohol cue reactivity and associated high-risk situations in an inter-mediating therapeutic context before the patients inevitably are confronted by them. In this way, one might expect the transition from treatment to daily life less overwhelming and CET may help prevent relapse in the long term. Thus, CET may be particularly suitable as aftercare.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
BACKGROUND It is well documented that individuals with Alcohol Use Disorders (AUD) respond well during Cognitive Behavioural Therapy, but that a large proportion of individuals relapse after treatment when confronted with alcohol in real life. Therefore, future treatment interventions for long-term prevention of relapse should aim to teach how to apply coping strategies and regain control over their alcohol cravings in their daily confrontations with alcohol and associated stimuli.
Cue Exposure Treatment (CET) is a behavioural psychological approach that focuses on confronting alcohol cues in order to reduce cravings as well as the likelihood of relapse. During CET individuals are exposed to alcohol related stimuli whilst their usual drink responses are hindered. Thus, they are given the opportunity to practice coping strategies during exposure to alcohol. In this way, it is predicted that individual's learned automatic responses will extinguish over time and that their cognitive control over cue reactivity strengthens.
Mental health care applications, has the potential to improve alcohol treatment and continuing care by offering psychological treatment anywhere and when the patient find it convenient. Because, psychological treatment is a substantial socio-economic burden when delivered in individual sessions, there has been a tendency to deliver the relevant treatment through group sessions. However, mental healthcare applications, have even more potential in order to reduce the burden on the health care system, in addition to increasing the availability of evidence-based treatment. Whilst group sessions are documented effective, behavioural healthcare applications targeting AUD needs further exploration.
OBJECTIVES
The objective of the study is three-fold:
- To investigate whether manual-based CET delivered via a smartphone or in group sessions increases the efficiency of CBT outpatient treatment in groups of AUD individuals.
- To investigate whether CET as a smartphone application is as or more effective than CET group therapy.
- To investigate whether CET as smartphone intervention will show to be more cost-effective than CET delivered in group sessions.
DESIGN AND METHODS The study is implemented as an investigator-blinded, randomized controlled trial. A total of 300 consecutively enrolled AUD individuals, recruited from an alcohol outpatient clinic will be randomized to one of the three following aftercare treatment groups: (1) CET as a smartphone application; (2) CET as group therapy, and (3) Standard aftercare treatment. Individuals in group 1 are required to use the smartphone application five times a week for eight weeks. Individuals in group 2 are required to have CET group therapy every other week for eight weeks. Individuals in group 3 will receive one individual follow-up session eight weeks after the primary treatment has ended.
It is hypothesized a priori that the two experimental groups will achieve better treatment outcomes as compared to the control group (3). No a priori hypotheses guides comparisons of the effect of CET delivered via group sessions and smartphone application. Two-sided analyses are conducted here, because there is no empirical literature in this specific area to generate a priori hypotheses.
The groups will be compared pre- and post-aftercare treatment, according to the following parameters:
- Relapse and alcohol intake, as measured with the Time-Line-Follow-Back (TLFB) method;
- Cravings, measured with Desires for Alcohol Questionnaire (DAQ), Obsessive-Compulsive Drinking Scale (OCDS), and Visual Analogue Scale for Craving (VAS);
Coping skills, operationalized with Urge-Specific Strategies Questionnaire (USS)
Data will be collected at three different time-points: before entering aftercare treatment (baseline), after eight weeks (follow-up), and again after six month (follow-up). In addition, we will follow the patients through medical registers for one year in order to measure relapse in the longer term, without the challenges associated with getting contact one year after ended treatment.
- Data from registers: The National Patient Register, The National Health Service Register, The National Prescription Registry and The Psychiatric Central Research Register.
Intention-to-treat analyses (ITT) will be carried out for all outpatients. With regard to incomplete data, "last observation carried forward" (LOCF) and multiple imputations will be used. Completer (on-treatment) analyses will be carried out for patients who have completed the respective interventions.
Odense Patient data Explorative Network (OPEN) data manager develops electronic schemes for data entry. Data will be imported and stored in OPEN Projects.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Odense, Danimarca, 5000
- Unit if Clinical Alcohol Research
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Completed primary treatment with CBT
- Accept participating in the study
Exclusion Criteria:
- Not Danish speaking
- Psychotic disorders
- Severe cognitive impairment
- Terminal somatic illness
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: CET via smartphone
Cue Exposure Treatment
|
|
|
Sperimentale: CET via group sessions
Cue Exposure Treatment
|
|
|
Nessun intervento: Aftercare as usual
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Alcohol consumption
Lasso di tempo: 26 weeks after baseline
|
Abstinence or controlled use of alcohol in the last 30 days 26 weeks after treatment start as measured with the timeline follow-back method
|
26 weeks after baseline
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Alcohol consumption
Lasso di tempo: 8 weeks after baseline
|
Abstinence or controlled use of alcohol in the last 30 days 8 weeks after treatment start as measured with the timeline follow-back method
|
8 weeks after baseline
|
|
Alcohol related contact with the Health Care system
Lasso di tempo: One year after baseline
|
Contact with the Health Care system one year after treatment start as measured by Danish registers
|
One year after baseline
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Cravings as measured by the Visual Analogue Craving Scale, Obsessive-Compulsive Drinking Scale and Desires for Alcohol Questionnaire
Lasso di tempo: 26 weeks after baseline
|
Cravings are measured by the Visual Analogue Craving Scale, Obsessive-Compulsive Drinking Scale and Desires for Alcohol Questionnaire
|
26 weeks after baseline
|
|
Cravings as measured by the Visual Analogue Craving Scale, Obsessive-Compulsive Drinking Scale and Desires for Alcohol Questionnaire
Lasso di tempo: 8 weeks after baseline
|
Cravings are measured by the Visual Analogue Craving Scale, Obsessive-Compulsive Drinking Scale and Desires for Alcohol Questionnaire
|
8 weeks after baseline
|
|
Coping skills as measured by The Urge-Specific Strategies Questionnaire
Lasso di tempo: 26 weeks after baseline
|
The Urge-Specific Strategies Questionnaire
|
26 weeks after baseline
|
|
Coping skills as measured by The Urge-Specific Strategies Questionnaire
Lasso di tempo: 8 weeks after baseline
|
The Urge-Specific Strategies Questionnaire
|
8 weeks after baseline
|
Collaboratori e investigatori
Sponsor
Pubblicazioni e link utili
Pubblicazioni generali
- Stryhn L, Larsen MB, Mejldal A, Sibbersen C, Nielsen DG, Nielsen B, Nielsen AS, Stenager E, Mellentin AI. Relapse prevention for alcohol use disorders: combined acamprosate and cue exposure therapy as aftercare. Nord J Psychiatry. 2022 Jul;76(5):394-402. doi: 10.1080/08039488.2021.1985169. Epub 2021 Oct 8.
- Mellentin AI, Nielsen B, Nielsen AS, Yu F, Mejldal A, Nielsen DG, Stenager E. A Mobile Phone App Featuring Cue Exposure Therapy As Aftercare for Alcohol Use Disorders: An Investigator-Blinded Randomized Controlled Trial. JMIR Mhealth Uhealth. 2019 Aug 16;7(8):e13793. doi: 10.2196/13793.
- Mellentin AI, Nielsen B, Nielsen AS, Yu F, Stenager E. A randomized controlled study of exposure therapy as aftercare for alcohol use disorder: study protocol. BMC Psychiatry. 2016 Apr 21;16:112. doi: 10.1186/s12888-016-0795-8.
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- Cue Exposure Study, RESCueH
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Disturbi da uso di alcol
-
Charite University, Berlin, GermanyReclutamentoSchizofrenia Spectrum Disorders (SSD)Germania
-
University of Trás-os-Montes and Alto DouroCentro Hospitalar De Trás-Os-Montes E Alto Douro, E.P.E.ReclutamentoDisturbi psicotici | Grave malattia mentale | Schizofrenia Spectrum Disorders (SSD)Portogallo
-
Central Institute of Mental Health, MannheimReclutamentoSchizofrenia Spectrum Disorders (SSD)Germania
-
Tianjin Medical University General HospitalReclutamentoNeuromielite Optica Spectrum Disorders (NMOSD)Cina
-
Tianjin Medical University General HospitalNon ancora reclutamentoNeuromielite ottica (NMO) | Neuromielite Optica Spectrum Disorders (NMOSD)
-
Huashan HospitalNon ancora reclutamentoNeuromielite Optica Spectrum Disorders (NMOSD)Cina
-
Huashan HospitalCompletato
-
Huashan HospitalShanghai AbelZeta Ltd.Non ancora reclutamentoEncefalite autoimmune | Sclerosi multipla (SM) | Sindrome della persona rigida | Neuromielite Optica Spectrum Disorders (NMOSD)
-
RenJi HospitalAbelZeta Pharma Inc.ReclutamentoMiastenia grave | Lupus eritematoso sistemico (LES) | Sclerosi multipla (SM) | Sclerosi sistemica (SSc) | Miopatia necrotizzante immunomediata (IMNM) | Neuromielite Optica Spectrum Disorders (NMOSD)Cina
Prove cliniche su Cue Exposure Treatment
-
Stanford UniversityUniversity of California, San Francisco; Iowa State University; Drexel University; Stanford Youth SolutionsCompletatoDisturbi da stress, post-traumaticiStati Uniti
-
Brigham and Women's HospitalNational Institute on Aging (NIA)CompletatoMalattie reumatiche | Lupus Eritematoso, Sistemico | Aderenza, Farmaco | GottaStati Uniti
-
Sungkyunkwan UniversityReclutamentoIctus ischemico | PropriocezioneCorea del Sud
-
David Reardon, MDCue BiopharmaReclutamentoGlioblastoma | Glioblastoma ricorrente | Glioma, malignoStati Uniti
-
Cue BiopharmaCompletatoTumore gastrico | Cancro colorettale | Tumore del pancreas | Cancro ovaricoStati Uniti
-
Wayne State UniversityNational Institute on Drug Abuse (NIDA)Completato
-
Yale UniversityNational Cancer Institute (NCI); Cue BiopharmaReclutamentoCarcinoma a cellule squamose della testa e del collo | Carcinoma a cellule squamose orofaringeo positivo per HPV | Nuova diagnosi tumore | Localmente AvanzatoStati Uniti
-
Brown UniversityNational Institute on Drug Abuse (NIDA)ReclutamentoUso di sostanze | Comportamento sanitario | Benessere, PsicologicoStati Uniti
-
University of Illinois at ChicagoNational Institute on Minority Health and Health Disparities (NIMHD); Sinai Urban...Non ancora reclutamento
-
Yonsei UniversityNon ancora reclutamentoFibrillazione atriale | Bradicardia | Tachicardia ventricolare | Tachicardia sopraventricolare | Ricovero | Aritmie | Monitoraggio del paziente | TelemetriaCorea del Sud